Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:focusesOn |
gptkb:biotechnology
gptkb:insurance Life sciences |
| gptkbp:formerName |
Advent Venture Partners
|
| gptkbp:foundedIn |
2010s
|
| gptkbp:headquartersLocation |
gptkb:London,_United_Kingdom
|
| gptkbp:industry |
Venture capital
|
| gptkbp:investedIn |
Early-stage companies
Growth-stage companies |
| gptkbp:managingPartner |
Raj Parekh
Genghis Lloyd-Harris Shahzad Malik |
| gptkbp:notableInvestment |
gptkb:Artios_Pharma
gptkb:Arrakis_Therapeutics F2G Aura Biosciences CN Bio Innovations |
| gptkbp:regionServed |
gptkb:Europe
gptkb:United_States |
| gptkbp:website |
https://www.adventls.com/
|
| gptkbp:bfsParent |
gptkb:Arrakis_Therapeutics
gptkb:Antiva_Biosciences |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Advent Life Sciences
|